Identification of LATS transcriptional targets in HeLa cells using whole human genome oligonucleotide microarray

Gene

Volumn 449, Issue 1-2, 2010, Pages 22-29

  Visser, Stacy ^a   Yang, Xiaolong ^a  

^a QUEEN S UNIVERSITY   (Canada)

Author keywords

Apoptosis; Cell migration; Cell proliferation; LATS1; LATS2; Microarray; Tumor suppressor

Indexed keywords

CYCLIN DEPENDENT KINASE INHIBITOR 1A; CYSTEINE RICH PROTEIN 61; DNA; LATS1 PROTEIN; LATS2 PROTEIN; PROTEIN P53; RAS PROTEIN; SLIT2 PROTEIN; TUMOR SUPPRESSOR PROTEIN; UNCLASSIFIED DRUG; WNT PROTEIN;

APOPTOSIS; ARTICLE; CELL ADHESION; CELL COMMUNICATION; CELL MIGRATION; CELL MOTILITY; CELL PROLIFERATION; CONTROLLED STUDY; DNA MICROARRAY; GENE LOSS; GENE TARGETING; GENETIC TRANSCRIPTION; HELA CELL; HUMAN; HUMAN CELL; HUMAN GENOME; NUCLEOTIDE SEQUENCE; PHENOTYPE; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN EXPRESSION; PROTEIN FUNCTION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; RNA INTERFERENCE; SIGNAL TRANSDUCTION; UNINDEXED SEQUENCE;

BASE SEQUENCE; CELL DEATH; CELL MOVEMENT; CELL PROLIFERATION; GENE EXPRESSION PROFILING; GENE KNOCKDOWN TECHNIQUES; GENOME, HUMAN; HELA CELLS; HUMANS; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; POLYMERASE CHAIN REACTION; PROTEIN-SERINE-THREONINE KINASES; RNA INTERFERENCE; RNA, SMALL INTERFERING; TRANSCRIPTION, GENETIC; TUMOR SUPPRESSOR PROTEINS;

EID: 70350416086     PISSN: 03781119     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.gene.2009.09.008     Document Type: Article

References (54)

1. Abe Y., Ohsugi M., Haraguchi K., Fujimoto J., and Yamamoto T. LATS2-Ajuba complex regulates gamma-tubulin recruitment to centrosomes and spindle organization during mitosis. FEBS Lett. 580 3 (2006) 782-788
2. Aylon Y., Michael D., Shmueli A., Yabuta N., Nojima H., and Oren M. A positive feedback loop between the p53 and Lats2 tumor suppressors prevents tetraploidization. Genes Dev. 20 19 (2006) 2687-2700
3. Bothos J., Tuttle R.L., Ottey M., Luca F.C., and Halazonetis T.D. Human LATS1 is a mitotic exit network kinase. Cancer Res. 65 15 (2005) 6568-6575
4. Bundschu K., Walter U., and Schuh K. Getting a first clue about SPRED functions. BioEssays : News Rev. Mol., Cell. Dev. Biol. 29 9 (2007) 897-907
5. Cabrita M.A., and Christofori G. Sprouty proteins, masterminds of receptor tyrosine kinase signaling. Angiogenesis 11 1 (2008) 53-62
6. Chan S.W., et al. A role for TAZ in migration, invasion, and tumorigenesis of breast cancer cells. Cancer Res. 68 8 (2008) 2592-2598
7. Dhillon A.S., Hagan S., Rath O., and Kolch W. MAP kinase signalling pathways in cancer. Oncogene 26 22 (2007) 3279-3290
8. el-Deiry W.S., et al. WAF1, a potential mediator of p53 tumor suppression. Cell 75 4 (1993) 817-825
9. Evan G.I., and Vousden K.H. Proliferation, cell cycle and apoptosis in cancer. Nature 411 6835 (2001) 342-348
10. Galletti E., Magnani M., Renzulli M.L., and Botta M. Paclitaxel and docetaxel resistance: molecular mechanisms and development of new generation taxanes. ChemMedChem 2 7 (2007) 920-942
11. Giles R.H., van Es J.H., and Clevers H. Caught up in a Wnt storm: Wnt signaling in cancer. Biochim. Biophys. Acta 1653 1 (2003) 1-24
12. Hanahan D., and Weinberg R.A. The hallmarks of cancer. Cell 100 1 (2000) 57-70
13. Hao Y., Chun A., Cheung K., Rashidi B., and Yang X. Tumor suppressor LATS1 is a negative regulator of oncogene YAP. J. Biol. Chem. 283 9 (2008) 5496-5509
14. Hisaoka M., Tanaka A., and Hashimoto H. Molecular alterations of h-warts/LATS1 tumor suppressor in human soft tissue sarcoma. Lab. Invest.; J. Tech. Methods Pathol. 82 10 (2002) 1427-1435
15. Hori T., Takaori-Kondo A., Kamikubo Y., and Uchiyama T. Molecular cloning of a novel human protein kinase, kpm, that is homologous to warts/lats, a Drosophila tumor suppressor. Oncogene 19 27 (2000) 3101-3109
16. Iida S., et al. Tumor suppressor WARTS ensures genomic integrity by regulating both mitotic progression and G1 tetraploidy checkpoint function. Oncogene 23 31 (2004) 5266-5274
17. Jiang Z., et al. Promoter hypermethylation-mediated down-regulation of LATS1 and LATS2 in human astrocytoma. Neurosci. Res. 56 4 (2006) 450-458
18. Jimenez-Velasco A., et al. Downregulation of the large tumor suppressor 2 (LATS2/KPM) gene is associated with poor prognosis in acute lymphoblastic leukemia. Leukemia : Off. J. Leukemia Society of America, Leukemia Res. Fund, U.K. 19 12 (2005) 2347-2350
19. Jordan M.A., Wendell K., Gardiner S., Derry W.B., Copp H., and Wilson L. Mitotic block induced in HeLa cells by low concentrations of paclitaxel (Taxol) results in abnormal mitotic exit and apoptotic cell death. Cancer Res. 56 4 (1996) 816-825
20. Kamikubo Y., Takaori-Kondo A., Uchiyama T., and Hori T. Inhibition of cell growth by conditional expression of kpm, a human homologue of Drosophila warts/lats tumor suppressor. J. Biol. Chem. 278 20 (2003) 17609-17614
21. Kassis J., Lauffenburger D.A., Turner T., and Wells A. Tumor invasion as dysregulated cell motility. Semin. Cancer Biol. 11 2 (2001) 105-117
22. Kawahara M., Hori T., Chonabayashi K., Oka T., Sudol M., and Uchiyama T. Kpm/Lats2 is linked to chemosensitivity of leukemic cells through the stabilization of p73. Blood 112 9 (2008) 3856-3866
23. Ke H., et al. Putative tumor suppressor Lats2 induces apoptosis through downregulation of Bcl-2 and Bcl-x(L). Exp. Cell Res. 298 2 (2004) 329-338
24. Kim H.J., and Bar-Sagi D. Modulation of signalling by Sprouty: a developing story. Nat. Rev. Mol. Cell Biol. 5 6 (2004) 441-450
25. Lau Y.K., Murray L.B., Houshmandi S.S., Xu Y., Gutmann D.H., and Yu Q. Merlin is a potent inhibitor of glioma growth. Cancer Res. 68 14 (2008) 5733-5742
26. Leask A., and Abraham D.J. All in the CCN family: essential matricellular signaling modulators emerge from the bunker. J. Cell Sci. 119 Pt 23 (2006) 4803-4810
27. Lei Q.Y., et al. TAZ promotes cell proliferation and epithelial-mesenchymal transition and is inhibited by the hippo pathway. Mol. Cell. Biol. 28 7 (2008) 2426-2436
28. Li Y., Pei J., Xia H., Ke H., Wang H., and Tao W. Lats2, a putative tumor suppressor, inhibits G1/S transition. Oncogene 22 28 (2003) 4398-4405
29. Lo T.L., Fong C.W., Yusoff P., McKie A.B., Chua M.S., Leung H.Y., and Guy G.R. Sprouty and cancer: the first terms report. Cancer Lett. 242 2 (2006) 141-150
30. McPherson J.P., Tamblyn L., Elia A., Migon E., Shehabeldin A., Matysiak-Zablocki E., Lemmers B., Salmena L., Hakem A., Fish J., Kassam F., Squire J., Bruneau B.G., Hande M.P., and Hakem R. Lats2/Kpm is required for embryonic development, proliferation control and genomic integrity. EMBO J. 23 18 (2004) 3677-3688
31. Mikeladze-Dvali T., et al. The growth regulators warts/lats and melted interact in a bistable loop to specify opposite fates in Drosophila R8 photoreceptors. Cell 122 5 (2005) 775-787
32. Okamura S., et al. p53DINP1, a p53-inducible gene, regulates p53-dependent apoptosis. Mol. cell 8 1 (2001) 85-94
33. Ota M., and Sasaki H. Mammalian Tead proteins regulate cell proliferation and contact inhibition as transcriptional mediators of Hippo signaling. Development (Cambridge, England) 135 24 (2008) 4059-4069
34. Overholtzer M., et al. Transforming properties of YAP, a candidate oncogene on the chromosome 11q22 amplicon. Proc. Natl. Acad. Sci. U. S. A. 103 33 (2006) 12405-12410
35. Pellock B.J., Buff E., White K., and Hariharan I.K. The Drosophila tumor suppressors Expanded and Merlin differentially regulate cell cycle exit, apoptosis, and Wingless signaling. Dev. Biol. 304 1 (2007) 102-115
36. Powzaniuk M., et al. The LATS2/KPM tumor suppressor is a negative regulator of the androgen receptor. Mol. Endocrinol. (Baltimore, Md.) 18 8 (2004) 2011-2023
37. Roman-Gomez J., et al. Promoter hypermethylation of cancer-related genes: a strong independent prognostic factor in acute lymphoblastic leukemia. Blood 104 8 (2004) 2492-2498
38. Saucedo L.J., and Edgar B.A. Filling out the Hippo pathway. Nat. Rev. Mol. Cell Biol. 8 8 (2007) 613-621
39. St John M.A., et al. Mice deficient of Lats1 develop soft-tissue sarcomas, ovarian tumours and pituitary dysfunction. Nat. Genet. 21 2 (1999) 182-186
40. Strazisar M., Mlakar V., and Glavac D. LATS2 tumour specific mutations and down-regulation of the gene in non-small cell carcinoma. Lung cancer 64 3 (2009) 257-262
41. Takahashi Y., et al. Down-regulation of LATS1 and LATS2 mRNA expression by promoter hypermethylation and its association with biologically aggressive phenotype in human breast cancers. Clin. Cancer Res. : Off. J. Am. Assoc. Cancer Res. 11 4 (2005) 1380-1385
42. Tao W., et al. Human homologue of the Drosophila melanogaster last tumour suppressor modulates CDC2 activity. Nat. Genet. 21 2 (1999) 177-181
43. Toji S., et al. The centrosomal protein Lats2 is a phosphorylation target of Aurora-A kinase. Genes Cells : Devoted to Molecular & Cellular Mechanisms 9 5 (2004) 383-397
44. Xia H., et al. LATS1 tumor suppressor regulates G2/M transition and apoptosis. Oncogene 21 8 (2002) 1233-1241
45. Xu T., Wang W., Zhang S., Stewart R.A., and Yu W. Identifying tumor suppressors in genetic mosaics: the Drosophila lats gene encodes a putative protein kinase. Development (Cambridge, England) 121 4 (1995) 1053-1063
46. Yabuta N., et al. Structure, expression, and chromosome mapping of LATS2, a mammalian homologue of the Drosophila tumor suppressor gene lats/warts. Genomics 63 2 (2000) 263-270
47. Yabuta N., et al. Lats2 is an essential mitotic regulator required for the coordination of cell division. J. Biol. Chem. 282 26 (2007) 19259-19271
48. Yamazaki D., Kurisu S., and Takenawa T. Regulation of cancer cell motility through actin reorganization. Cancer Sci. 96 7 (2005) 379-386
49. Yang X., Li D.M., Chen W., and Xu T. Human homologue of Drosophila lats, LATS1, negatively regulate growth by inducing G(2)/M arrest or apoptosis. Oncogene 20 45 (2001) 6516-6523
50. Yang X., et al. LATS1 tumour suppressor affects cytokinesis by inhibiting LIMK1. Nat. Cell Biol. 6 7 (2004) 609-617
51. Zhang J., Smolen G.A., and Haber D.A. Negative regulation of YAP by LATS1 underscores evolutionary conservation of the Drosophila Hippo pathway. Cancer Res. 68 8 (2008) 2789-2794
52. Zhao B., et al. Inactivation of YAP oncoprotein by the Hippo pathway is involved in cell contact inhibition and tissue growth control. Genes Dev. 21 21 (2007) 2747-2761
53. Zhao B., Lei Q.Y., and Guan K.L. The Hippo-YAP pathway: new connections between regulation of organ size and cancer. Curr. Opin. Cell Biol. 20 6 (2008) 638-646
54. Zhao B., et al. TEAD mediates YAP-dependent gene induction and growth control. Genes Dev. 22 14 (2008) 1962-1971